Building of a prediction model for liver toxicity and hepatocarcinogenicity based on SELDI-TOF MS spectra

被引：0
|
作者：
Beyer, S
Ittrich, C
Kopp-Schneider, A
Kramer, PJ
Hellmann, J
Kröger, M
机构：
[1] Merck KGaA, Inst Tox, D-64293 Darmstadt, Germany
[2] DKFZ, D-69009 Heidelberg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [31] Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS
    Gast, Marie-Christine W.
    Van Gils, Carla H.
    Wessels, Lodewijk F. A.
    Harris, Nathan
    Bonfrer, Johannes M. G.
    Rutgers, Emiel J. Th.
    Schellens, Jan H. M.
    Beijnen, Jos H.
    ONCOLOGY REPORTS, 2009, 22 (01) : 205 - 213
  • [32] SELDI-TOF MS-based discovery of a biomarker in Cucumis sativus seeds exposed to CuO nanoparticles
    Moon, Young-Sun
    Park, Eun-Sil
    Kim, Tae-Oh
    Lee, Hoi-Seon
    Lee, Sung-Eun
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2014, 38 (03) : 922 - 931
  • [33] Proteomic analysis of serum biomarkers in patients with nonalcoholic steatohepatitis using SELDI-TOF/MS or MALDI-TOF/MS
    Uto, Hirofumi
    Sato, Yuko
    Ishida, Yoichi
    Takami, Yoichiro
    Kanmura, Shuji
    Moriuchi, Akihiro
    Hasegawa, Susumu
    Oketani, Makoto
    Ido, Akio
    Nakajima, Tomoaki
    Okanoue, Takeshi
    Tsubouchi, Horohito
    HEPATOLOGY, 2007, 46 (04) : 735A - 736A
  • [34] Global proteomics in AML:: Using SELDI-TOF MS on diagnostic samples to identify spectra and protein biomarkers indicative of prognosis
    Stenke, Leif
    Pememalm, Maria
    Forshed, Jenny
    Pawitan, Yodi
    Lagergren-Lindberg, Marita
    Kanter, Lena
    Lehtio, Janne
    BLOOD, 2006, 108 (11) : 187B - 187B
  • [35] Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling
    Albrethsen, Jakob
    Kaas, Anne
    Schoenle, Eugen
    Swift, Peter
    Kocova, Mirjana
    Gammeltoft, Steen
    Hansen, Lars
    Mortensen, Henrik Bindesbol
    PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (03) : 383 - 393
  • [36] Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling
    Gast, Marie-Christine W.
    Engwegen, Judith Y. M. N.
    Schellens, Jan H. M.
    Beijnen, Jos H.
    BMC MEDICAL GENOMICS, 2008, 1 (1)
  • [37] Determining the primary site of metastatic adenocarcinoma in liver by SELDI-TOF mass spectrometry
    Balco, Mike
    Mezzadra, Heather
    Kincaid, Erik
    Tambouret, Rosemary
    Altiok, Soner
    CANCER CYTOPATHOLOGY, 2006, 108 (05) : 407 - 407
  • [38] Comparison of Normalization Methods for the Identification of Biomarkers Using MALDI-TOF and SELDI-TOF Mass Spectra
    Borgaonkar, Sanket P.
    Hocker, Harrison
    Shin, Hyunjin
    Markey, Mia K.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2010, 14 (01) : 115 - 126
  • [39] SELDI-TOF MS室内质量控制的初步研究
    陈蓉艳
    兰小鹏
    实用医学杂志, 2009, 25 (12) : 2074 - 2076
  • [40] Identification of αB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS
    Holcakova, J.
    Hernychova, L.
    Bouchal, P.
    Brozkova, K.
    Zaloudik, J.
    Valik, D.
    Nenutil, R.
    Vojtesek, B.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (01): : 48 - 53
12345